{"id":"W1989944891","doi":"10.1517/14712598.8.7.1011","title":"Adalimumab for the treatment of Crohn's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Crohn's disease; Monoclonal antibody; Disease; Monoclonal; Internal medicine; Inflammatory bowel disease; Clinical trial; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006415047,0.0004832472,0.0006823068,0.00003611211,0.0001502951,0.00001135646,0.000397962,0.0003712557,0.00005489685],"category_scores_gemma":[0.00005479755,0.0002272975,0.001288294,0.00005380798,0.0002295393,0.000001239111,0.00002938775,0.00005902676,0.00001290005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004170224,"about_ca_system_score_gemma":0.0001835365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001799119,"about_ca_topic_score_gemma":1.791659e-7,"domain_scores_codex":[0.9984024,0.0002403806,0.0004142754,0.0005547435,0.0001195875,0.0002686089],"domain_scores_gemma":[0.9986309,0.0001705958,0.0002431594,0.0007566084,0.00005750871,0.0001412235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001809295,0.0006387816,0.000005549492,0.00005120252,0.0003155275,0.00001838424,0.00002017472,0.000002000093,0.00001979541,0.0001568001,0.003513324,0.9934492],"study_design_scores_gemma":[0.0008450646,0.001402074,0.0003460679,0.0002015969,0.000003406594,0.00000368677,0.000004998795,0.00000195526,0.00004183624,0.000017571,0.9968437,0.0002880707],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001805479,0.9967329,0.00006611549,0.00005042164,0.0005416479,0.002060834,0.0003034579,0.00001959281,0.00004451503],"genre_scores_gemma":[0.00007118464,0.995475,0.00005777349,0.0002904126,0.001236094,0.001744945,0.001016226,0.00004567184,0.00006272376],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9933304,"threshold_uncertainty_score":0.9268922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.116582758874184,"score_gpt":0.3832660486252241,"score_spread":0.2666832897510401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}